UBS AM’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.6M Sell
964,479
-366,517
-28% -$27.1M 0.01% 562
2026
Q1
$83.5M Buy
1,330,996
+70,616
+6% +$4.47M 0.02% 541
2025
Q4
$83.7M Sell
1,260,380
-499,109
-28% -$24.5M 0.02% 524
2025
Q3
$60.7M Sell
1,759,489
-924,828
-34% -$20.3M 0.01% 569
2025
Q2
$42.4M Sell
2,684,317
-2,100,745
-44% -$30.1M 0.01% 746
2025
Q1
$61M Buy
4,785,062
+2,774,933
+138% +$50.5M 0.02% 643
2024
Q4
$37.8M Sell
2,010,129
-144,121
-7% -$2.97M 0.01% 735
2024
Q3
$41.7M Sell
2,154,250
-135,904
-6% -$3.32M 0.01% 712
2024
Q2
$59.5M Buy
2,290,154
+1,356,254
+145% +$33.3M 0.02% 572
2024
Q1
$26.7M Sell
933,900
-17,394
-2% -$556K 0.01% 717
2023
Q4
$29.1M Buy
951,294
+210,412
+28% +$5.59M 0.01% 701
2023
Q3
$19.9M Buy
740,882
+203,917
+38% +$6.25M 0.01% 763
2023
Q2
$13.6M Hold
536,965
0.01% 860
2023
Q1
$13.6M Buy
536,965
+39,044
+8% +$1.23M 0.01% 860
2022
Q4
$20.2M Buy
497,921
+411,561
+477% +$13.6M 0.01% 756
2022
Q3
$2.85M Sell
86,360
-23,365
-21% -$943K ﹤0.01% 1414
2022
Q2
$3.86M Sell
109,725
-4,161
-4% -$157K ﹤0.01% 1311
2022
Q1
$5.24M Buy
113,886
+16,777
+17% +$831K ﹤0.01% 1334
2021
Q4
$6.44M Sell
97,109
-1,383
-1% -$95K ﹤0.01% 1300
2021
Q3
$6.15M Buy
98,492
+10,831
+12% +$701K ﹤0.01% 1270
2021
Q2
$7.26M Sell
87,661
-3,800
-4% -$283K ﹤0.01% 1226
2021
Q1
$6.06M Sell
91,461
-26,135
-22% -$2.03M ﹤0.01% 1265
2020
Q4
$9.02M Buy
117,596
+11,477
+11% +$734K ﹤0.01% 1094
2020
Q3
$4.57M Buy
106,119
+945
+0.9% +$40.8K ﹤0.01% 1188
2020
Q2
$4.54M Buy
105,174
+16,277
+18% +$574K ﹤0.01% 1154
2020
Q1
$2.56M Sell
88,897
-1,197
-1% -$48.3K ﹤0.01% 1318
2019
Q4
$5.71M Sell
90,094
-1,037
-1% -$51.5K ﹤0.01% 1140
2019
Q3
$2.57M Buy
91,131
+13,814
+18% +$409K ﹤0.01% 1490
2019
Q2
$2.05M Buy
77,317
+36,142
+88% +$793K ﹤0.01% 1578
2019
Q1
$756K Sell
41,175
-14,089
-25% -$232K ﹤0.01% 1931
2018
Q4
$686K Sell
55,264
-12,002
-18% -$164K ﹤0.01% 1873
2018
Q3
$1.29M Buy
67,266
+18,184
+37% +$298K ﹤0.01% 1706
2018
Q2
$668K Buy
+49,082
New +$459K ﹤0.01% 1977
2017
Q2
Sell
-66,400
Closed -$123K 2532
2017
Q1
$123K Buy
66,400
+53,500
+415% +$106K ﹤0.01% 2275
2016
Q4
$20K Sell
12,900
-10,900
-46% -$46.4K ﹤0.01% 2352
2016
Q3
$175K Hold
23,800
﹤0.01% 2496
2016
Q2
$127K Hold
23,800
﹤0.01% 2556
2016
Q1
$115K Sell
23,800
-15,600
-40% -$65.8K ﹤0.01% 2549
2015
Q4
$242K Buy
39,400
+3,500
+10% +$19.8K ﹤0.01% 2445
2015
Q3
$207K Buy
35,900
+14,700
+69% +$92.4K ﹤0.01% 2479
2015
Q2
$152K Hold
21,200
﹤0.01% 2637
2015
Q1
$143K Buy
21,200
+1,400
+7% +$9.94K ﹤0.01% 2545
2014
Q4
$146K Buy
19,800
+5,200
+36% +$35.4K ﹤0.01% 2530
2014
Q3
$216K Buy
14,600
+900
+7% +$12.3K ﹤0.01% 2328
2014
Q2
$196K Buy
+13,700
New +$180K ﹤0.01% 2418

Other funds holding ARWR

UBS AM's ARWR Position: Q2 2026 in Review

UBS AM reduced its Arrowhead Research (ARWR) stake by 28% in Q2 2026, selling an estimated $27.1M and leaving 964,479 shares worth $78.6M. The position accounts for 0.01% of the portfolio, ranked #562.

UBS AM first reported a position in ARWR in Q2 2014 and has held it in 45 quarters since. The position peaked at $83.7M in Q4 2025. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

  • UBS AM held 964,479 shares of Arrowhead Research worth $78.6M as of Q2 2026.
  • UBS AM sold 366,517 Arrowhead Research shares in Q2 2026, an estimated $27.1M.
  • Arrowhead Research made up 0.01% of UBS AM's portfolio in Q2 2026, its #562 holding.
  • UBS AM first reported a position in Arrowhead Research in Q2 2014 and has held it in 45 quarters since.
  • UBS AM's Arrowhead Research position peaked at $83.7M in Q4 2025.
  • 500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.